We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00659399
Recruitment Status : Withdrawn (Low accrual)
First Posted : April 16, 2008
Last Update Posted : March 18, 2015
Information provided by:
New York University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : September 2010
  Estimated Study Completion Date : November 2010